Advertisement

Anaesthetic and Perioperative Management for Liver Transplantation

  • Antonio SiniscalchiEmail author
  • Elisabetta Pierucci
  • Stefano Faenza

Abstract

This chapter concerns about perioperative anaesthesiologic management of liver transplantation.

Liver cirrhosis and its complications often involve different organs whose derangements could severely worsen postoperative outcome; hence, their preoperative diagnosis and treatment are fundamental; the first part of this chapter describes the most frequent complications of cirrhosis and their implications in preoperative care.

Liver transplantation is a challenging task for the anaesthesiologist because of the risk of bleeding, cardiovascular derangements, coagulation impairment and metabolic disturbances; the second part of this chapter describes the main anaesthetic and monitoring techniques used for liver transplantations and the most important intraoperative problems which need to be faced by the anaesthesiologist in each phase of the intervention.

Early postoperative management of liver transplant recipients is crucial because of their comorbidities and the potential surgical and medical complications of the intervention; the third part of this chapter describes the ICU management after liver transplantation and the main medical complications for every organ system that needs a critical care approach.

Keywords

Hepatic Encephalopathy Liver Graft Acute Kidney Injury Network Early Extubation Central Pontine Myelinolysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–35. doi: 10.1002/hep.27210.PubMedGoogle Scholar
  2. 2.
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–21. doi: 10.1053/jhep.2002.31250.PubMedGoogle Scholar
  3. 3.
    Córdoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011;54:1030–40. doi: 10.1016/j.jhep.2010.11.015.PubMedGoogle Scholar
  4. 4.
    Lockwood AH. Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis. 2004;19:345–9.PubMedGoogle Scholar
  5. 5.
    Chavarria L, Alonso J, García-Martínez R, Simón-Talero M, Ventura-Cots M, Ramírez C, et al. Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy. J Cereb Blood Flow Metab. 2013;33:272–7. doi: 10.1038/jcbfm.2012.173.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Grønbaek H, Johnsen SP, Jepsen P, Gislum M, Vilstrup H, Tage-Jensen U, et al. Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study. BMC Gastroenterol. 2008;8:16. doi: 10.1186/1471-230X-8-16.PubMedCentralPubMedGoogle Scholar
  7. 7.
    Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144–65.PubMedGoogle Scholar
  8. 8.
    Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19:3–26. doi: 10.1002/lt.23566.PubMedGoogle Scholar
  9. 9.
    Herrero JI, Bilbao JI, Diaz ML, Alegre F, Inarrairaegui M, Pardo F, et al. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: treatment with embolization of portosystemic collaterals. Liver Transpl. 2009;15:111–4. doi: 10.1002/lt.21552.PubMedGoogle Scholar
  10. 10.
    Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:S121–31. doi: 10.1002/hep.20993.PubMedGoogle Scholar
  11. 11.
    Hennenberg M, Trebicka J, Sauerbruch T, Heller J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut. 2008;57:1300–14. doi: 10.1136/gut.2007.144584.PubMedGoogle Scholar
  12. 12.
    Vaughan RB, Angus PW, Chin-Dusting JPF. Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation. Gut. 2003;52:1505–10.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Hall TH, Dhir A. Anesthesia for liver transplantation. Semin Cardiothorac Vasc Anesth. 2013;17:180–94. doi: 10.1177/1089253213481115.PubMedGoogle Scholar
  14. 14.
    Møller S, Bendtsen F, Henriksen JH. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scand J Gastroenterol. 2005;40:491–500. doi: 10.1080/00365520510012064.PubMedGoogle Scholar
  15. 15.
    Biancofiore G, Mandell MS, Rocca G, Della. Perioperative considerations in patients with cirrhotic cardiomyopathy. Curr Opin Anaesthesiol. 2010;23:128–32. doi: 10.1097/ACO.0b013e328337260a.PubMedGoogle Scholar
  16. 16.
    Møller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. Int J Cardiol. 2013;167:1101–8. doi: 10.1016/j.ijcard.2012.09.089.PubMedGoogle Scholar
  17. 17.
    Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y. Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg. 1996;2:426–30.PubMedGoogle Scholar
  18. 18.
    Appleton CP, Hurst RT. Reducing coronary artery disease events in liver transplant patients: moving toward identifying the vulnerable patient. Liver Transpl. 2008;14:1691–3. doi: 10.1002/lt.21660.PubMedGoogle Scholar
  19. 19.
    Gologorsky E, Pretto EA, Fukazawa K. Coronary artery disease and its risk factors in patients presenting for liver transplantation. J Clin Anesth. 2013;25:618–23. doi: 10.1016/j.jclinane.2013.06.001.PubMedGoogle Scholar
  20. 20.
    Yong CM, Sharma M, Ochoa V, Abnousi F, Roberts J, Bass NM, et al. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation. Liver Transpl. 2010;16:1242–8. doi: 10.1002/lt.22152.PubMedGoogle Scholar
  21. 21.
    Tiukinhoy-Laing SD, Rossi JS, Bayram M, De Luca L, Gafoor S, Blei A, et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation. Am J Cardiol. 2006;98:178–81. doi: 10.1016/j.amjcard.2006.01.089.PubMedGoogle Scholar
  22. 22.
    Rodríquez-Roisin R, Krowka MJ, Hervé P, Fallon MB. Highlights of the ERS task force on pulmonary-hepatic vascular disorders (PHD). J Hepatol. 2005;42:924–7.PubMedGoogle Scholar
  23. 23.
    Machicao VI, Fallon MB. Hepatopulmonary syndrome. Semin Respir Crit Care Med. 2012;33:11–6. doi: 10.1055/s-0032-1301730.PubMedGoogle Scholar
  24. 24.
    Hemprich U, Papadakos PJ, Lachmann B. Respiratory failure and hypoxemia in the cirrhotic patient including hepatopulmonary syndrome. Curr Opin Anaesthesiol. 2010;23:133–8. doi: 10.1097/ACO.0b013e328335f024.PubMedGoogle Scholar
  25. 25.
    Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24:861–80. doi: 10.1183/09031936.04.00010904.PubMedGoogle Scholar
  26. 26.
    Colle IO, Moreau R, Godinho E, Belghiti J, Ettori F, Cohen-Solal A, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003;37:401–9. doi: 10.1053/jhep.2003.50060.PubMedGoogle Scholar
  27. 27.
    Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006;44:1502–10. doi: 10.1002/hep.21431.PubMedGoogle Scholar
  28. 28.
    Murray KF, Carithers RL. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005;41:1407–32. doi: 10.1002/hep.20704.PubMedGoogle Scholar
  29. 29.
    Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59:1627–37. doi: 10.1002/hep.26745.PubMedGoogle Scholar
  30. 30.
    Fritz JS, Fallon MB, Kawut SM. Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med. 2013;187:133–43. doi: 10.1164/rccm.201209-1583CI.PubMedCentralPubMedGoogle Scholar
  31. 31.
    Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol. 2013;59:367–74. doi: 10.1016/j.jhep.2013.03.026.PubMedGoogle Scholar
  32. 32.
    Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol. 2012;18:3035–49. doi: 10.3748/wjg.v18.i24.3035.PubMedCentralPubMedGoogle Scholar
  33. 33.
    Meltzer J, Brentjens TE. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies. Curr Opin Anaesthesiol. 2010;23:139–44. doi: 10.1097/ACO.0b013e32833724a8.PubMedGoogle Scholar
  34. 34.
    Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361:1279–90. doi: 10.1056/NEJMra0809139.PubMedGoogle Scholar
  35. 35.
    Steadman RH, Van Rensburg A, Kramer DJ. Transplantation for acute liver failure: perioperative management. Curr Opin Organ Transplant. 2010;15:368–73. doi: 10.1097/MOT.0b013e32833982dd.PubMedGoogle Scholar
  36. 36.
    Cárdenas A, Uriz J, Ginès P, Arroyo V. Hepatorenal syndrome. Liver Transpl. 2000;6:S63–71.PubMedGoogle Scholar
  37. 37.
    Angeli P, Morando F, Cavallin M, Piano S. Hepatorenal syndrome. Contrib Nephrol. 2011;174:46–55. doi: 10.1159/000329235.PubMedGoogle Scholar
  38. 38.
    Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón JM, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol. 2000;33:43–8.PubMedGoogle Scholar
  39. 39.
    Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol. 2003;18:152–6.PubMedGoogle Scholar
  40. 40.
    Rahimi RS, Rockey DC. Complications of cirrhosis. Curr Opin Gastroenterol. 2012;28:223–9. doi: 10.1097/MOG.0b013e328351d003.PubMedGoogle Scholar
  41. 41.
    Takikawa Y, Harada M, Wang T, Suzuki K. Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease. Hepatol Res. 2014;44:92–101. doi: 10.1111/hepr.12093.PubMedGoogle Scholar
  42. 42.
    Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147–56. doi: 10.1056/NEJMra1011170.PubMedGoogle Scholar
  43. 43.
    Steib A, Freys G, Lehmann C, Meyer C, Mahoudeau G. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth. 2001;48:1075–9. doi: 10.1007/BF03020372.PubMedGoogle Scholar
  44. 44.
    Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol. 2010;53:362–71. doi: 10.1016/j.jhep.2010.01.042.PubMedGoogle Scholar
  45. 45.
    Martinez J, MacDonald KA, Palascak JE. The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains. Blood. 1983;61:1196–202.PubMedGoogle Scholar
  46. 46.
    Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44:1039–46. doi: 10.1002/hep.21303.PubMedGoogle Scholar
  47. 47.
    Hannaman MJ, Hevesi ZG. Anesthesia care for liver transplantation. Transplant Rev (Orlando). 2011;25:36–43. doi: 10.1016/j.trre.2010.10.004.Google Scholar
  48. 48.
    Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, et al. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology. 2003;38:230–7. doi: 10.1053/jhep.2003.50277.PubMedGoogle Scholar
  49. 49.
    Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, et al. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology. 2001;121:131–9.PubMedGoogle Scholar
  50. 50.
    Lisman T, Leebeek FWG. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250–8. doi: 10.1159/000103655.PubMedGoogle Scholar
  51. 51.
    Wiklund RA. Preoperative preparation of patients with advanced liver disease. Crit Care Med. 2004;32:S106–15.PubMedGoogle Scholar
  52. 52.
    DeWolf AM, Kang YG, Todo S, Kam I, Francavilla AJ, Polimeno L, et al. Glucose metabolism during liver transplantation in dogs. Anesth Analg. 1987;66:76–80.PubMedCentralPubMedGoogle Scholar
  53. 53.
    Ehtisham J, Altieri M, Salamé E, Saloux E, Ollivier I, Hamon M. Coronary artery disease in orthotopic liver transplantation: pretransplant assessment and management. Liver Transpl. 2010;16:550–7. doi: 10.1002/lt.22035.PubMedGoogle Scholar
  54. 54.
    Vogt DP, Henderson JM, Carey WD, Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery. 2002;132:775–80; discussion 780.PubMedGoogle Scholar
  55. 55.
    Aydinalp A, Bal U, Atar I, Ertan C, Aktaş A, Yildirir A, et al. Value of stress myocardial perfusion scanning in diagnosis of severe coronary artery disease in liver transplantation candidates. Transplant Proc. 2009;41:3757–60. doi: 10.1016/j.transproceed.2009.06.219.PubMedGoogle Scholar
  56. 56.
    Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg. 2002;183:595–9.PubMedGoogle Scholar
  57. 57.
    Keeling AN, Flaherty JD, Davarpanah AH, Ambrosy A, Farrelly CT, Harinstein ME, et al. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown). 2011;12:460–8. doi: 10.2459/JCM.0b013e3283483916.Google Scholar
  58. 58.
    Burger-Klepp U, Karatosic R, Thum M, Schwarzer R, Fuhrmann V, Hetz H, et al. Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagoastric varices. Transplantation. 2012;94:192–6. doi: 10.1097/TP.0b013e31825475c2.PubMedGoogle Scholar
  59. 59.
    López-Candales A, Menendez FL, Shah SA, Friedrich A. Measures of right ventricular systolic function in end stage liver disease patients awaiting transplant. Int J Cardiol. 2014;171:277–8. doi: 10.1016/j.ijcard.2013.11.088.PubMedGoogle Scholar
  60. 60.
    Nanashima A, Pillay P, Crawford M, Nakasuji M, Verran DJ, Painter D. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. J Hepatobiliary Pancreat Surg. 2001;8:557–63. doi: 10.1007/s005340100025.PubMedGoogle Scholar
  61. 61.
    Perilli V, Avolio AW, Sacco T, Modesti C, Gaspari R, Caserta R, et al. Use of an esophageal echo-Doppler device during liver transplantation: preliminary report. Transpl Proc. 2009;41:198–200. doi: 10.1016/j.transproceed.2008.09.054.Google Scholar
  62. 62.
    Schober P, Loer SA, Schwarte LA. Perioperative hemodynamic monitoring with transesophageal Doppler technology. Anesth Analg. 2009;109:340–53. doi: 10.1213/ane.0b013e3181aa0af3.PubMedGoogle Scholar
  63. 63.
    Della Rocca G, Costa GM, Coccia C, Pompei L, Di Marco P, Pietropaoli P. Preload index: pulmonary artery occlusion pressure versus intrathoracic blood volume monitoring during lung transplantation. Anesth Analg. 2002;95:835–43, table of contents.PubMedGoogle Scholar
  64. 64.
    Feltracco P, Brezzi M, Barbieri S, Galligioni H, Milevoj M, Carollo C, et al. Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation. World J Hepatol. 2013;5:1–15. doi: 10.4254/wjh.v5.i1.1.PubMedCentralPubMedGoogle Scholar
  65. 65.
    Wang S-C, Lin H-T, Chang K-Y, Mandell MS, Ting C-K, Chu Y-C, et al. Use of higher thromboelastogram transfusion values is not associated with greater blood loss in liver transplant surgery. Liver Transpl. 2012;18:1254–8. doi: 10.1002/lt.23494.PubMedGoogle Scholar
  66. 66.
    Kim JA, Lee JJ, Kim CS, Chung IS, Gwak MS, Kim GS. Does general anesthesia with inhalation anesthetics worsen hypoxemia in patients with end-stage liver disease and an intrapulmonary shunt? Transplant Proc. 2011;43:1665–8. doi: 10.1016/j.transproceed.2011.03.056.PubMedGoogle Scholar
  67. 67.
    Futier E, Constantin J-M, Paugam-Burtz C, Pascal J, Eurin M, Neuschwander A, et al. A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013;369:428–37. doi: 10.1056/NEJMoa1301082.PubMedGoogle Scholar
  68. 68.
    Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190–201. doi: 10.1016/S0140-6736(10)60274-7.PubMedGoogle Scholar
  69. 69.
    Molin SZFD, Kruel CRP, de Fraga RS, Alboim C, de Oliveira JR, Alvares-da-Silva MR. Differential protective effects of anaesthesia with sevoflurane or isoflurane: an animal experimental model simulating liver transplantation. Eur J Anaesthesiol. 2014. doi: 10.1097/EJA.0000000000000127.Google Scholar
  70. 70.
    Steadman RH. Anesthesia for liver transplant surgery. Anesthesiol Clin North America. 2004;22:687–711. doi: 10.1016/j.atc.2004.06.009.PubMedGoogle Scholar
  71. 71.
    Marcel RJ, Ramsay MA, Hein HA, Nguyen AT, Ramsay KJ, Suit CT, et al. Duration of rocuronium-induced neuromuscular block during liver transplantation: a predictor of primary allograft function. Anesth Analg. 1997;84:870–4.PubMedGoogle Scholar
  72. 72.
    De Wolf AM, Freeman JA, Scott VL, Tullock W, Smith DA, Kisor DF, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth. 1996;76:624–8.PubMedGoogle Scholar
  73. 73.
    Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol. 2014;20:6146–58. doi: 10.3748/wjg.v20.i20.6146.PubMedCentralPubMedGoogle Scholar
  74. 74.
    Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30:270–382. doi: 10.1097/EJA.0b013e32835f4d5b.PubMedGoogle Scholar
  75. 75.
    Dalmau A, Sabaté A, Aparicio I. Hemostasis and coagulation monitoring and management during liver transplantation. Curr Opin Organ Transplant. 2009;14:286–90. doi: 10.1097/MOT.0b013e32832a6b7c.PubMedGoogle Scholar
  76. 76.
    Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl. 2013;19:852–61. doi: 10.1002/lt.23668.PubMedGoogle Scholar
  77. 77.
    Mallett SV, Chowdary P, Burroughs AK. Clinical utility of viscoelastic tests of coagulation in patients with liver disease. Liver Int. 2013;33:961–74. doi: 10.1111/liv.12158.PubMedGoogle Scholar
  78. 78.
    Tripodi A, Primignani M, Chantarangkul V, Viscardi Y, Dell’Era A, Fabris FM, et al. The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters. Thromb Res. 2009;124:132–6. doi: 10.1016/j.thromres.2008.11.008.PubMedGoogle Scholar
  79. 79.
    Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137:209–20. doi: 10.1378/chest. 09-0252.PubMedGoogle Scholar
  80. 80.
    Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion. 2006;46:919–33. doi: 10.1111/j.1537-2995.2006.00824.x.PubMedGoogle Scholar
  81. 81.
    Shao Y-F, Yang J-M, Chau G-Y, Sirivatanauksorn Y, Zhong S-X, Erhardtsen E, et al. Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Surg. 2006;191:245–9. doi: 10.1016/j.amjsurg.2005.10.019.PubMedGoogle Scholar
  82. 82.
    Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus. 2010;8:149–54. doi: 10.2450/2010.0149-09.PubMedCentralPubMedGoogle Scholar
  83. 83.
    Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, et al. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013;13:22. doi: 10.1186/1471-2482-13-22.PubMedCentralPubMedGoogle Scholar
  84. 84.
    Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion. 2006;46:1279–85. doi: 10.1111/j.1537-2995.2006.00891.x.PubMedGoogle Scholar
  85. 85.
    Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy–a porcine model. Br J Anaesth. 2006;97:460–7. doi: 10.1093/bja/ael191.PubMedGoogle Scholar
  86. 86.
    Henry DA, Carless PA, Moxey AJ, O’Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;(1):CD001886. doi: 10.1002/14651858.CD001886.pub4.
  87. 87.
    Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJH, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2007;7:185–94. doi: 10.1111/j.1600-6143.2006.01591.x.PubMedGoogle Scholar
  88. 88.
    Görlinger K. Coagulation management during liver transplantation. Hamostaseologie. 2006;26:S64–76.PubMedGoogle Scholar
  89. 89.
    Steib A, Gengenwin N, Freys G, Boudjema K, Levy S, Otteni JC. Predictive factors of hyperfibrinolytic activity during liver transplantation in cirrhotic patients. Br J Anaesth. 1994;73:645–8.PubMedGoogle Scholar
  90. 90.
    Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg. 1995;81:360–5.PubMedGoogle Scholar
  91. 91.
    Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, et al. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One. 2011;6:e22581. doi: 10.1371/journal.pone.0022581.PubMedCentralPubMedGoogle Scholar
  92. 92.
    Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791–800. doi: 10.1056/NEJMoa1006221.PubMedGoogle Scholar
  93. 93.
    Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M, et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology. 2011;115:1179–91. doi: 10.1097/ALN.0b013e31823497dd.PubMedGoogle Scholar
  94. 94.
    Gurusamy KS, Pissanou T, Pikhart H, Vaughan J, Burroughs AK, Davidson BR. Methods to decrease blood loss and transfusion requirements for liver transplantation. Cochrane Database Syst Rev. 2011;(12):CD009052. doi: 10.1002/14651858.CD009052.pub2.
  95. 95.
    Massicotte L, Denault AY, Beaulieu D, Thibeault L, Hevesi Z, Nozza A, et al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation. 2012;93:1276–81. doi: 10.1097/TP.0b013e318250fc25.PubMedGoogle Scholar
  96. 96.
    Mukhtar A, Salah M, Aboulfetouh F, Obayah G, Samy M, Hassanien A, et al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med. 2011;39:1329–34. doi: 10.1097/CCM.0b013e3182120842.PubMedGoogle Scholar
  97. 97.
    Delva E, Nordlinger B, Parc R, Lienhart A, Hannoun L, Huguet C. Hepatic vascular exclusion (HVE) for major liver resections. Int Surg. 1987;72:78–81.PubMedGoogle Scholar
  98. 98.
    Wszolek ZK, McComb RD, Pfeiffer RF, Steg RE, Wood RP, Shaw BW, et al. Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation. 1989;48:1006–12.PubMedGoogle Scholar
  99. 99.
    Scott VL, De Wolf AM, Kang Y, Altura BT, Virji MA, Cook DR, et al. Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication. Liver Transpl Surg. 1996;2:343–7.PubMedGoogle Scholar
  100. 100.
    Levi DM, Pararas N, Tzakis AG, Nishida S, Tryphonopoulos P, Gonzalez-Pinto I, et al. Liver transplantation with preservation of the inferior vena cava: lessons learned through 2,000 cases. J Am Coll Surg. 2012;214:691–8. doi: 10.1016/j.jamcollsurg.2011.12.039; discussion 698–9.PubMedGoogle Scholar
  101. 101.
    Vieira de Melo PS, Miranda LEC, Batista LL, Neto OCLF, Amorim AG, Sabat BD, et al. Orthotopic liver transplantation without venovenous bypass using the conventional and piggyback techniques. Transplant Proc. 2011;43:1327–33. doi: 10.1016/j.transproceed.2011.03.061.PubMedGoogle Scholar
  102. 102.
    Fonouni H, Mehrabi A, Soleimani M, Müller SA, Büchler MW, Schmidt J. The need for venovenous bypass in liver transplantation. HPB (Oxford). 2008;10:196–203. doi: 10.1080/13651820801953031.Google Scholar
  103. 103.
    Rossi G, Langer M, Maggi U, Reggiani P, Caccamo L, Gatti S, et al. Veno-venous bypass versus no bypass in orthotopic liver transplantation: hemodynamic, metabolic, and renal data. Transplant Proc. 1998;30:1871–3.PubMedGoogle Scholar
  104. 104.
    Prager MC, Gregory GA, Ascher NL, Roberts JP. Massive venous air embolism during orthotopic liver transplantation. Anesthesiology. 1990;72:198–200.PubMedGoogle Scholar
  105. 105.
    Calne RY, Rolles K, Farman JV, Kneeshaw JD, Smith DP, Wheeldon DR. Veno-arterial bypass in orthotopic liver grafting. Lancet. 1984;2:1269.PubMedGoogle Scholar
  106. 106.
    Kaufman RD, Khoury GF. Hemodynamic changes with initiation of veno-venous bypass in orthotopic liver transplant patients. Am J Anesthesiol. 1995;22:184–8.PubMedGoogle Scholar
  107. 107.
    Shangraw RE, Winter R, Hromco J, Robinson ST, Gallaher EJ. Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Anesthesiology. 1994;81:1127–38.PubMedGoogle Scholar
  108. 108.
    Ramsay M. The reperfusion syndrome: have we made any progress? Liver Transpl. 2008;14:412–4. doi: 10.1002/lt.21418.PubMedGoogle Scholar
  109. 109.
    Paugam-Burtz C, Kavafyan J, Merckx P, Dahmani S, Sommacale D, Ramsay M, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl: Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc. 2009;15:522–9. doi: 10.1002/lt.21730.Google Scholar
  110. 110.
    Cheng SS, Berman GW, Merritt GR, Hendrickse A, Fiegel MJ, Teitelbaum I, et al. The response to methylene blue in patients with severe hypotension during liver transplantation. J Clin Anesth. 2012;24:324–8. doi: 10.1016/j.jclinane.2011.10.010.PubMedGoogle Scholar
  111. 111.
    Zhang L, Li M, Yang L. Effects of different vasopressors on hemodynamics in patients undergoing orthotopic liver transplantation. Chin Med J (Engl). 2005;118:1952–8.Google Scholar
  112. 112.
    De Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HGD, Slooff MJH, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg. 2008;106:32–44. doi: 10.1213/01.ane.0000289638.26666.ed, table of contents.PubMedGoogle Scholar
  113. 113.
    Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth. 1997;78:175–9.PubMedGoogle Scholar
  114. 114.
    Kettner SC, Gonano C, Seebach F, Sitzwohl C, Acimovic S, Stark J, et al. Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation. Anesth Analg. 1998;86:691–5.PubMedGoogle Scholar
  115. 115.
    Agarwal S, Senzolo M, Melikian C, Burroughs A, Mallett SV. The prevalence of a heparin-like effect shown on the thromboelastograph in patients undergoing liver transplantation. Liver Transpl. 2008;14:855–60. doi: 10.1002/lt.21437.PubMedGoogle Scholar
  116. 116.
    Glanemann M, Busch T, Neuhaus P, Kaisers U. Fast tracking in liver transplantation. Immediate postoperative tracheal extubation: feasibility and clinical impact. Swiss Med Wkly. 2007;137:187–91. doi:2007/13/smw-11681.PubMedGoogle Scholar
  117. 117.
    Biancofiore G, Bindi ML, Romanelli AM, Boldrini A, Bisà M, Esposito M, et al. Fast track in liver transplantation: 5 years’ experience. Eur J Anaesthesiol. 2005;22:584–90.PubMedGoogle Scholar
  118. 118.
    Mandell MS, Lezotte D, Kam I, Zamudio S. Reduced use of intensive care after liver transplantation: influence of early extubation. Liver Transpl. 2002;8:676–81. doi: 10.1053/jlts.2002.34379.PubMedGoogle Scholar
  119. 119.
    Jullien T, Valtier B, Hongnat JM, Dubourg O, Bourdarias JP, Jardin F. Incidence of tricuspid regurgitation and vena caval backward flow in mechanically ventilated patients. A color Doppler and contrast echocardiographic study. Chest. 1995;107:488–93.PubMedGoogle Scholar
  120. 120.
    Chastre J. Conference summary: ventilator-associated pneumonia. Respir Care. 2005;50:975–83.PubMedGoogle Scholar
  121. 121.
    Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: a review. Chest. 2004;126:249–58. doi: 10.1378/chest.126.1.249.PubMedGoogle Scholar
  122. 122.
    Antonelli M, Conti G, Bufi M, Costa MG, Lappa A, Rocco M, et al. Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial. JAMA. 2000;283:235–41.PubMedGoogle Scholar
  123. 123.
    Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000;342:1301–8. doi: 10.1056/NEJM200005043421801.
  124. 124.
    Steltzer H, Hiesmayr M, Tüchy G, Zimpfer M. Perioperative liver graft function: the role of oxygen transport and utilization. Anesth Analg. 1993;76:574–9.PubMedGoogle Scholar
  125. 125.
    Mandell MS, Tsou M-Y. The development of perioperative practices for liver transplantation: advances and current trends. J Chin Med Assoc. 2008;71:435–41. doi: 10.1016/S1726-4901(08)70145-X.PubMedGoogle Scholar
  126. 126.
    Mukhtar A, EL Masry A, Moniem AA, Metini M, Fayez A, Khater YH. The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study. Transplant Proc. 2007;39:3214–8. doi: 10.1016/j.transproceed.2007.06.084.PubMedGoogle Scholar
  127. 127.
    Ramos E, Dalmau A, Sabate A, Lama C, Llado L, Figueras J, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl. 2003;9:1320–7. doi: 10.1016/jlts.2003.50204.PubMedGoogle Scholar
  128. 128.
    Barri YM, Sanchez EQ, Jennings LW, Melton LB, Hays S, Levy MF, et al. Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl. 2009;15:475–83. doi: 10.1002/lt.21682.PubMedGoogle Scholar
  129. 129.
    Foxton MR, Al-Freah MAB, Portal AJ, Sizer E, Bernal W, Auzinger G, et al. Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl. 2010;16:668–77. doi: 10.1002/lt.22027.PubMedGoogle Scholar
  130. 130.
    Bahirwani R, Reddy KR. Outcomes after liver transplantation: chronic kidney disease. Liver Transpl. 2009;15 Suppl 2:S70–4. doi: 10.1002/lt.21900.PubMedGoogle Scholar
  131. 131.
    Cabezuelo JB, Ramírez P, Ríos A, Acosta F, Torres D, Sansano T, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006;69:1073–80. doi: 10.1038/sj.ki.5000216.PubMedGoogle Scholar
  132. 132.
    Ferreira AC, Nolasco F, Carvalho D, Sampaio S, Baptista A, Pessegueiro P, et al. Impact of RIFLE classification in liver transplantation. Clin Transplant. 2010;24:394–400. doi: 10.1111/j.1399-0012.2009.01087.x.PubMedGoogle Scholar
  133. 133.
    Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–12. doi: 10.1186/cc2872.PubMedCentralPubMedGoogle Scholar
  134. 134.
    O’Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant. 2007;7:168–76. doi: 10.1111/j.1600-6143.2006.01602.x.PubMedGoogle Scholar
  135. 135.
    Greig PD, Woolf GM, Abecassis M, Forster J, Strasberg SM, Taylor BR, et al. Prostaglandin E1 for primary nonfunction following liver transplantation. Transplant Proc. 1989;21:3360–1.PubMedGoogle Scholar
  136. 136.
    Estrin JA, Belani KG, Ascher NL, Lura D, Payne W, Najarian JS. Hemodynamic changes on clamping and unclamping of major vessels during liver transplantation. Transplant Proc. 1989;21:3500–5.PubMedGoogle Scholar
  137. 137.
    Biancofiore G, Bindi L, Romanelli AM, Bisà M, Boldrini A, Consani G, et al. Renal failure and abdominal hypertension after liver transplantation: determination of critical intra-abdominal pressure. Liver Transpl. 2002;8:1175–81. doi: 10.1053/jlts.2002.36246.PubMedGoogle Scholar
  138. 138.
    Niemann CU, Walia A, Waldman J, Davio M, Roberts JP, Hirose R, et al. Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl. 2009;15:1852–60. doi: 10.1002/lt.21938.PubMedGoogle Scholar
  139. 139.
    Martin M, Neumann D, Hoff T, Resch K, DeWitt DL, Goppelt-Struebe M. Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int. 1994;45:150–8.PubMedGoogle Scholar
  140. 140.
    Lee JP, Heo NJ, Joo KW, Yi NJ, Suh K-S, Moon KC, et al. Risk factors for consequent kidney impairment and differential impact of liver transplantation on renal function. Nephrol Dial Transplant. 2010;25:2772–85. doi: 10.1093/ndt/gfq093.PubMedGoogle Scholar
  141. 141.
    Gibney N, Cerda J, Davenport A, Ramirez J, Singbartl K, Leblanc M, et al. Volume management by renal replacement therapy in acute kidney injury. Int J Artif Organs. 2008;31:145–55.PubMedGoogle Scholar
  142. 142.
    Davenport A, Farrington K. Dialysis dose in acute kidney injury and chronic dialysis. Lancet. 2010;375:705–6. doi: 10.1016/S0140-6736(09)62062-6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Antonio Siniscalchi
    • 1
    Email author
  • Elisabetta Pierucci
    • 1
  • Stefano Faenza
    • 1
  1. 1.Division of AnesthesiologyAlma Mater Studiorum University of BolognaBolognaItaly

Personalised recommendations